These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2814516)

  • 1. Use of defibrotide in the treatment of acute myocardial infarction.
    Milazzotto F; Carelli M; Citone C; Di Marcotullio G; Giampaolo P; Malinconico U; Polizzi C; Tubaro M; Giovannini E; Boccardi L
    Semin Thromb Hemost; 1989 Oct; 15(4):464-9. PubMed ID: 2814516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of acute myocardial infarction with defibrotide.
    Mattioli G; Cappello C; Fusaro MT
    Semin Thromb Hemost; 1989 Oct; 15(4):470-3. PubMed ID: 2814517
    [No Abstract]   [Full Text] [Related]  

  • 3. A pilot evaluation of the effects of defibrotide in patients affected by acute myocardial infarction.
    Carelli M; Citone C; Di Marcotullio G; Giampaolo P; Malinconico U; Polizzi C; Dell'Edera N; Gambelli GC; Cornelli U; Milazzotto F
    Semin Thromb Hemost; 1988; 14 Suppl():71-6. PubMed ID: 3194768
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of oral and intravenous defibrotide on blood viscosity in patients with peripheral obliterative arterial disease.
    Belfiglio A; Traietti P; Bologna E; Salvo G
    Clin Ther; 1989; 11(4):479-84. PubMed ID: 2776165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardioprotective effects of defibrotide: a minireview.
    Pescador R; Porta R; Mantovani M; Prino G
    Semin Thromb Hemost; 1991; 17 Suppl 1():96-100. PubMed ID: 2068573
    [No Abstract]   [Full Text] [Related]  

  • 6. Endothelial protection by defibrotide--a new strategy for treatment of myocardial infarction?
    Schrör K; Ackermann G; Hohlfeld T; Löbel P; Ney P; Schröder H; Strobach H
    Z Kardiol; 1989; 78 Suppl 6():35-41. PubMed ID: 2559554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind, multicenter, placebo-controlled, dose comparison study of orally administered defibrotide: preliminary results in patients with peripheral arterial disease.
    Strano A; Fareed J; Sabbá C; Albano O; Allegra C; Carlizza A; Binaghi F; Fronteddu F; Del Guercio R; Arpaia MR
    Semin Thromb Hemost; 1991; 17 Suppl 2():228-34. PubMed ID: 1948094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombolytic activity of defibrotide against old venous thrombi.
    Niada R; Porta R; Pescador R; Mantovani M; Prino G
    Semin Thromb Hemost; 1989 Oct; 15(4):474-9. PubMed ID: 2510300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bolus fibrinolysis in acute myocardial infarction].
    Zeymer U
    Dtsch Med Wochenschr; 2002 Oct; 127(40):2083-6. PubMed ID: 12373644
    [No Abstract]   [Full Text] [Related]  

  • 10. Fibrinolytic effects of defibrotide in atherosclerotic patients.
    Patrassi GM; Sartori MT; Viero ML; Scapinello MP; Boeri G; Girolami A
    Semin Thromb Hemost; 1991; 17 Suppl 1():101-5. PubMed ID: 2068562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of defibrotide in the treatment of acute superficial thrombophlebitis of the legs].
    Seccia M; Bortolotti P; Bellomini MG; Buccianti P; Chiarugi M; Cavina E
    Minerva Chir; 1989 May; 44(9):1379-84. PubMed ID: 2761740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacoinvasive therapy: the future of treatment for ST-elevation myocardial infarction.
    Antman EM; Van de Werf F
    Circulation; 2004 Jun; 109(21):2480-6. PubMed ID: 15173037
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of defibrotide on physical performance and hemorheologic picture in patients with peripheral arteriopathy.
    Marrapodi E; Leanza D; Giordano S; Nazzari M; Corsi C
    Clin Trials Metaanal; 1994 Apr; 29(1):21-30. PubMed ID: 10150182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anaphylactic shock to defibrotide.
    Artesani MC
    Allergy; 2006 Aug; 61(8):1022. PubMed ID: 16867061
    [No Abstract]   [Full Text] [Related]  

  • 15. Improvement of walking distance by defibrotide in patients with intermittent claudication--results of a randomized, placebo-controlled study (the DICLIS study). Defibrotide Intermittent CLaudication Italian Study.
    Violi F; Marubini E; Coccheri S; Nenci GG
    Thromb Haemost; 2000 May; 83(5):672-7. PubMed ID: 10823260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevention of deep venous thrombosis. A prospective study of defibrotide].
    Mensa G; Dominici P; Bouzari H; Colarelli G; Capusotti L; Dellepiane M
    Minerva Chir; 1988 Aug; 43(15-16):1275-8. PubMed ID: 3060758
    [No Abstract]   [Full Text] [Related]  

  • 17. Update on the use of defibrotide.
    Guglielmelli T; Bringhen S; Palumbo A
    Expert Opin Biol Ther; 2012 Mar; 12(3):353-61. PubMed ID: 22283742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Thrombolytic therapy in acute myocardial infarction at the pre-hospital stage].
    Varshavskiĭ SIu; Fel'dman SKh; Zhuravlev KV; Borisov MV; Loginovskaia OA
    Klin Med (Mosk); 1991 Apr; 69(4):38-40. PubMed ID: 1865648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of free radicals in the cardioprotective effect of defibrotide.
    Haklar G; Erşahin C; Moini H; Süngün M; Doğan N; Bilsel S; Emerk K; Yalçin AS
    Arzneimittelforschung; 1996 Apr; 46(4):381-4. PubMed ID: 8740083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defibrotide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in vascular disorders.
    Palmer KJ; Goa KL
    Drugs; 1993 Feb; 45(2):259-94. PubMed ID: 7681375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.